<SEC-DOCUMENT>0001013594-15-000159-index.html : 20150220
<SEC-HEADER>0001013594-15-000159.hdr.sgml : 20150220
<ACCEPTANCE-DATETIME>20150220170241
ACCESSION NUMBER:		0001013594-15-000159
CONFORMED SUBMISSION TYPE:	SC 13G
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20150220
DATE AS OF CHANGE:		20150220

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NAVIDEA BIOPHARMACEUTICALS, INC.
		CENTRAL INDEX KEY:			0000810509
		STANDARD INDUSTRIAL CLASSIFICATION:	IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
		IRS NUMBER:				311080091
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13G
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-43603
		FILM NUMBER:		15636542

	BUSINESS ADDRESS:	
		STREET 1:		5600 BLAZER PARKWAY
		STREET 2:		SUITE 200
		CITY:			DUBLIN
		STATE:			OH
		ZIP:			43017
		BUSINESS PHONE:		6147937500

	MAIL ADDRESS:	
		STREET 1:		5600 BLAZER PARKWAY
		STREET 2:		SUITE 200
		CITY:			DUBLIN
		STATE:			OH
		ZIP:			43017

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NEOPROBE CORP
		DATE OF NAME CHANGE:	19940714

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Platinum Partners Value Arbitrage Fund, LP
		CENTRAL INDEX KEY:			0001299265
		IRS NUMBER:				141861954
		STATE OF INCORPORATION:			E9
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13G

	BUSINESS ADDRESS:	
		STREET 1:		152 WEST 57TH STREET
		STREET 2:		54TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10019
		BUSINESS PHONE:		212-581-0500

	MAIL ADDRESS:	
		STREET 1:		152 WEST 57TH STREET
		STREET 2:		54TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10019
</SEC-HEADER>
<DOCUMENT>
<TYPE>SC 13G
<SEQUENCE>1
<FILENAME>navidea13g-022015.htm
<DESCRIPTION>FEBRUARY 20, 2015
<TEXT>
Document 1 - file: navidea13g-022015.htm

</DOCUMENT>
</SEC-DOCUMENT>